title: [Continuous subcutaneous insulin infusion in type 1 diabetic during pregnancy: case report and literature review].
abstract: The type 1 diabetic patient pregnancy is subjected to various attempts to obtain good glycemic control, since the pre-conception period throughout the gestation. Continuous subcutaneous insulin infusion (CSII) is a therapeutic tool to achieve the glycemic targets. Here it is presented the case of a Type 1 diabetic woman, who was not under multiple insulin daily injections therapy, and whose insulin therapy started on CSII during the second trimester of gestation, obtaining successful therapeutic outcome.
authors.affiliation: Serviço de Endocrinologia e Metabologia, Santa Casa de Belo Horizonte, MG, Brasil. janicesepulveda@terra.com.br
authors.forename: Janice Sepúlveda
authors.initials: JS
authors.lastname: Reis
authors.forename: Rodrigo Nunes
authors.initials: RN
authors.lastname: Lamounier
authors.forename: Patrícia A F C
authors.initials: PA
authors.lastname: Menezes
authors.forename: Maria R
authors.initials: MR
authors.lastname: Calsolari
authors.forename: Saulo
authors.initials: S
authors.lastname: Purisch
mesh_terms: D000279:Administration, Cutaneous; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D015918:Infusion Pumps, Implantable; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D011247:Pregnancy; D011256:Pregnancy Outcome; D011262:Pregnancy Trimester, Second; D011254:Pregnancy in Diabetics; D055815:Young Adult
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin